Science Explorer Back to mapMap
Discussion
Company · Tarrytown · United States

Regeneron (United States)

In research, Regeneron (United States) stands highest in Health Sciences (#480 of 9,902 worldwide), Medicine (#468 of 8,541 worldwide) and Life Sciences (#363 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Dermatology, Immunology and Immunology and Microbiology (Dermatology is 15.2× its share of world research).

regeneron.comROR OpenAlex
World rank, 2022-now
#1,081
of 22,385 · #807 all time
Rank in United States
#238
of 3,332
Research works
1.9k
▲ 50% vs 2018-21
Citations
135k
70.0 per fractional work
Top-10% rate
14.5%
all institutions 10.0%
vs its own fields
1.13×
1.00× is exactly expected
Open access
54%
world 40%
International
27%
world 18%
Regeneron (United States)

What is Regeneron (United States) known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #480 of 9,902 15.5%387 #341
MedicineField #468 of 8,541 15.7%376 #336
Life SciencesDomain #363 of 6,403 15.2%218 #261
Biochemistry, Genetics and Molecular BiologyField #236 of 2,964 14.7%138 #176
Molecular BiologySubfield #232 of 1,880 14.0%87 #159
Immunology and MicrobiologyField #166 of 681 16.9%60 #205

Each strip is that field's whole ranked pool, with the notch where Regeneron (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Health Sciences#341 #480
  2. Medicine#336 #468
  3. Life Sciences#261 #363
  4. Biochemistry, Genetics and Molecular Biology#176 #236
  5. Molecular Biology#159 #232
  6. Immunology and Microbiology#205 #166
all time2022-now, better2022-now, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

Which fields of science does Regeneron (United States) work in?

In 2022-now, 58% of research at Regeneron (United States) is in Health Sciences, 33% in Life Sciences. Its largest fields are Medicine (57%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (9%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 439 fractional works · 58.4% of its workMedicine: 426 fractional works · 56.7% of its workOncology: 50 fractional works · 6.7% of its workPhysiology: 42 fractional works · 5.6% of its workRadiology, Nuclear Medicine and Imaging: 38 fractional works · 5.1% of its workSurgery: 38 fractional works · 5.0% of its workPulmonary and Respiratory Medicine: 34 fractional works · 4.5% of its workDermatology: 30 fractional works · 4.0% of its workRheumatology: 22 fractional works · 2.9% of its workEpidemiology: 18 fractional works · 2.4% of its workInfectious Diseases: 17 fractional works · 2.3% of its workImmunology and Allergy: 16 fractional works · 2.2% of its workHematology: 16 fractional works · 2.1% of its workCardiology and Cardiovascular Medicine: 13 fractional works · 1.7% of its workPathology and Forensic Medicine: 11 fractional works · 1.5% of its workOphthalmology: 10 fractional works · 1.3% of its workGenetics: 9 fractional works · 1.2% of its workNeurology: 9 fractional works · 1.2% of its workEndocrinology, Diabetes and Metabolism: 9 fractional works · 1.1% of its workPublic Health, Environmental and Occupational Health: 7 fractional works · 0.9% of its workNephrology: 5 fractional works · 0.7% of its workOtorhinolaryngology: 5 fractional works · 0.7% of its workPediatrics, Perinatology and Child Health: 4 fractional works · 0.5% of its workPharmacology: 4 fractional works · 0.5% of its workHepatology: 3 fractional works · 0.4% of its workPsychiatry and Mental health: 2 fractional works · 0.3% of its workReproductive Medicine: 2 fractional works · 0.3% of its workSmaller subfields together: 12 fractional works · 1.6% of its workHealth Professions: 9 fractional works · 1.2% of its workEmergency Medical Services: 2 fractional works · 0.3% of its workGeneral Health Professions: 2 fractional works · 0.3% of its workOccupational Therapy: 2 fractional works · 0.2% of its workSmaller subfields together: 3 fractional works · 0.4% of its workNursing: 2 fractional works · 0.3% of its workNutrition and Dietetics: 2 fractional works · 0.3% of its workVeterinary: 1 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.1% of its workLife Sciences: 247 fractional works · 33.0% of its workBiochemistry, Genetics and Molecular Biology: 154 fractional works · 20.5% of its workMolecular Biology: 97 fractional works · 12.9% of its workGenetics: 32 fractional works · 4.3% of its workCancer Research: 10 fractional works · 1.3% of its workCell Biology: 5 fractional works · 0.6% of its workBiotechnology: 4 fractional works · 0.6% of its workSmaller subfields together: 6 fractional works · 0.8% of its workImmunology and Microbiology: 70 fractional works · 9.3% of its workImmunology: 68 fractional works · 9.1% of its workSmaller subfields together: 1 fractional works · 0.2% of its workNeuroscience: 16 fractional works · 2.1% of its workCellular and Molecular Neuroscience: 5 fractional works · 0.7% of its workNeurology: 3 fractional works · 0.4% of its workSensory Systems: 3 fractional works · 0.4% of its workCognitive Neuroscience: 2 fractional works · 0.2% of its workSmaller subfields together: 3 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 5 fractional works · 0.6% of its workPharmaceutical Science: 3 fractional works · 0.4% of its workSmaller subfields together: 2 fractional works · 0.2% of its workAgricultural and Biological Sciences: 4 fractional works · 0.5% of its workPlant Science: 2 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 0.3% of its workPhysical Sciences: 45 fractional works · 6.0% of its workEngineering: 15 fractional works · 2.0% of its workBiomedical Engineering: 12 fractional works · 1.6% of its workSmaller subfields together: 2 fractional works · 0.3% of its workMathematics: 12 fractional works · 1.6% of its workStatistics and Probability: 11 fractional works · 1.5% of its workSmaller subfields together: 1 fractional works · 0.2% of its workChemistry: 9 fractional works · 1.1% of its workSpectroscopy: 7 fractional works · 0.9% of its workOrganic Chemistry: 2 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.1% of its workComputer Science: 5 fractional works · 0.6% of its workArtificial Intelligence: 2 fractional works · 0.3% of its workSmaller subfields together: 3 fractional works · 0.3% of its workEnvironmental Science: 2 fractional works · 0.2% of its workMaterials Science: 1 fractional works · 0.2% of its workPhysics and Astronomy: 1 fractional works · 0.1% of its workEarth and Planetary Sciences: 0 fractional works · 0.0% of its workChemical Engineering: 0 fractional works · 0.0% of its workSocial Sciences: 19 fractional works · 2.6% of its workEconomics, Econometrics and Finance: 8 fractional works · 1.1% of its workEconomics and Econometrics: 8 fractional works · 1.1% of its workSmaller subfields together: 0 fractional works · 0.0% of its workSocial Sciences: 4 fractional works · 0.6% of its workSociology and Political Science: 2 fractional works · 0.3% of its workSmaller subfields together: 2 fractional works · 0.3% of its workPsychology: 3 fractional works · 0.4% of its workDecision Sciences: 3 fractional works · 0.4% of its workBusiness, Management and Accounting: 1 fractional works · 0.1% of its workALL ITS WORKRegeneron (UnitedStates)751fractional works, 2022-now
Life Sciences33%Physical Sciences6%Health Sciences58%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 26 fields, with their numbers
    1. Medicine42656.7%
    2. Health Professions91.2%
    3. Nursing20.3%
    4. Veterinary10.1%
    5. Dentistry00.1%
    1. Biochemistry, Genetics and Molecular Biology15420.5%
    2. Immunology and Microbiology709.3%
    3. Neuroscience162.1%
    4. Pharmacology, Toxicology and Pharmaceutics50.6%
    5. Agricultural and Biological Sciences40.5%
    1. Engineering152.0%
    2. Mathematics121.6%
    3. Chemistry91.1%
    4. Computer Science50.6%
    5. Environmental Science20.2%
    6. Materials Science10.2%
    7. Physics and Astronomy10.1%
    8. Earth and Planetary Sciences00.0%
    9. Chemical Engineering00.0%
    10. Energy00.0%
    1. Economics, Econometrics and Finance81.1%
    2. Social Sciences40.6%
    3. Psychology30.4%
    4. Decision Sciences30.4%
    5. Business, Management and Accounting10.1%
    6. Arts and Humanities00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Regeneron (United States) specialise in?

Where its research is concentrated relative to its size: Dermatology takes 15.2× the share of its output that it takes of world research.

  1. DermatologySubfield · 30.0 works15×
  2. ImmunologySubfield · 68.2 works13×
  3. Immunology and MicrobiologyField · 69.7 works9.2×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.10× its world share, 4 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.84× its world share, 154 worksBiochemistry, Geneti…Immunology and Microbiology: 9.22× its world share, 70 worksImmunology and Micro…Neuroscience: 1.29× its world share, 16 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.82× its world share, 5 worksPharmacology, Toxico…Chemical Engineering: 0.13× its world share, 0 worksChemical EngineeringChemistry: 0.73× its world share, 9 worksChemistryComputer Science: 0.08× its world share, 5 worksComputer ScienceEarth and Planetary Sciences: 0.03× its world share, 0 worksEarth and Planetary …Energy: 0.01× its world share, 0 worksEnergyEngineering: 0.13× its world share, 15 worksEngineeringEnvironmental Science: 0.05× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.05× its world share, 1 worksMaterials ScienceMathematics: 1.40× its world share, 12 worksMathematicsPhysics and Astronomy: 0.06× its world share, 1 worksPhysics and AstronomyDentistry: 0.11× its world share, 0 worksDentistryHealth Professions: 0.47× its world share, 9 worksHealth ProfessionsMedicine: 2.95× its world share, 426 worksMedicineNursing: 0.63× its world share, 2 worksNursingVeterinary: 0.83× its world share, 1 worksVeterinaryArts and Humanities: 0.01× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.03× its world share, 1 worksBusiness, Management…Decision Sciences: 0.39× its world share, 3 worksDecision SciencesEconomics, Econometrics and Finance: 0.51× its world share, 8 worksEconomics, Econometr…Psychology: 0.14× its world share, 3 worksPsychologySocial Sciences: 0.05× its world share, 4 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.2×. Every wedge is a field page.

All 26 fields, with their numbers
  1. Immunology and Microbiology9.22×70 works
  2. Biochemistry, Genetics and Molecular Biology3.84×154 works
  3. Medicine2.95×426 works
  4. Pharmacology, Toxicology and Pharmaceutics1.82×5 works
  5. Mathematics1.40×12 works
  6. Neuroscience1.29×16 works
  7. Veterinary0.83×1 works
  8. Chemistry0.73×9 works
  9. Nursing0.63×2 works
  10. Economics, Econometrics and Finance0.51×8 works
  11. Health Professions0.47×9 works
  12. Decision Sciences0.39×3 works
  13. Psychology0.14×3 works
  14. Chemical Engineering0.13×0 works
  15. Engineering0.13×15 works
  16. Dentistry0.11×0 works
  17. Agricultural and Biological Sciences0.10×4 works
  18. Computer Science0.08×5 works
  19. Physics and Astronomy0.06×1 works
  20. Environmental Science0.05×2 works
  21. Materials Science0.05×1 works
  22. Social Sciences0.05×4 works
  23. Earth and Planetary Sciences0.03×0 works
  24. Business, Management and Accounting0.03×1 works
  25. Energy0.01×0 works
  26. Arts and Humanities0.01×0 works

Who are the top researchers at Regeneron (United States)?

Ranked on the quality score, George D. Yancopoulos, Aris Baras and Jeffrey G. Reid lead among researchers whose main affiliation is Regeneron (United States).

  1. 1 George D. Yancopoulos United States · #54 worldwide 168k citations · 669 works
  2. 2 Aris Baras United States · #2,550 worldwide 26k citations · 243 works
  3. 3 Jeffrey G. Reid United States · #2,763 worldwide 65k citations · 194 works
  4. 4 Neil I Stahl United States · #3,173 worldwide 49k citations · 163 works
  5. 5 Andrew J. Murphy United States · #7,617 worldwide 33k citations · 446 works
  6. 6 Lukas Habegger United States · #9,613 worldwide 81k citations · 118 works
  7. 7 Alicia C. Hawes United States · #10,306 worldwide 39k citations · 81 works
  8. 8 Suganthi Balasubramanian United States · #12,334 worldwide 80k citations · 122 works
  9. 9 John D. Overton United States · #12,533 worldwide 24k citations · 207 works
  10. 10 Gavin Thurston United States · #13,293 worldwide 32k citations · 486 works
All ranked researchers at Regeneron (United States)

What are the most cited papers from Regeneron (United States)?

The most cited paper from Regeneron (United States) is "Vascular-specific growth factors and blood vessel formation" (George D. Yancopoulos, Samuel H. Davis, Nicholas W. Gale et al., 2000), with 3,706 citations. Next come "Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome" (3,654) and "Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis" (3,588).

Most cited papers
#PaperReleasedCitations
1 Vascular-specific growth factors and blood vessel formation George D. Yancopoulos, Samuel H. Davis, Nicholas W. Gale et al. · Nature Sep 2000 3,706
2 Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome Gregory G. Schwartz et al. · New England Journal of Medicine Open access 7 Nov 2018 3,654
3 Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis Peter C. Maisonpierre, Chitra Suri, Pamela F. Jones et al. · Science 4 Jul 1997 3,588
4 Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy Sue C. Bodine, Esther Latres, Susanne Baumhueter et al. · Science Open access 23 Nov 2001 3,550
5 The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function Jesse M. Cedarbaum, Nancy Stambler, Errol Malta et al. · Journal of the Neurological Sciences Oct 1999 3,349
All 59 most cited papers, with filters and sorting

Which keywords describe research at Regeneron (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Monoclonal Antibodies, Inflammation, Therapeutic Antibodies, Treatment, Glycosylation, Diagnosis and Management.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology101▲ 3.4×77 topics
  2. Inflammation73▲ 4.6×66 topics
  3. Monoclonal Antibodies64▲ 95×3 topics
  4. Treatment58▲ 6.3×32 topics
  5. Therapeutic Antibodies55▲ 105×2 topics
  6. Diagnosis50▲ 7.1×27 topics
  7. Glycosylation48▲ 58×3 topics
  8. Management42▲ 7.0×17 topics
  9. Asthma37▲ 50×2 topics
  10. Biopharmaceuticals36▲ 93×3 topics
  11. Genetics35▲ 6.6×14 topics
  12. Immunogenicity33▲ 103×3 topics
  13. Immunotherapy32▲ 5.9×19 topics
  14. Quality of Life32▲ 2.9×23 topics
  15. Antibody Engineering31▲ 75×1 topic
  16. Fc Receptors31▲ 75×1 topic
  17. Clinical Trials28▲ 5.7×14 topics
  18. Immunology28▲ 35×2 topics
  19. Allergic Diseases28▲ 63×1 topic
  20. Eosinophils28▲ 63×1 topic
  21. Cancer Immunotherapy28▲ 24×3 topics
  22. Recombinant Proteins27▲ 113×2 topics
  23. Lymphoma26▲ 22×4 topics
  24. Protein Aggregation26▲ 65×3 topics
  25. Immune Dysregulation25▲ 42×2 topics
  26. Staphylococcus aureus25▲ 43×2 topics
  27. Filaggrin24▲ 66×1 topic
  28. Skin Microbiome24▲ 66×1 topic
  29. Stability24▲ 14×2 topics
  30. Chromatography24▲ 212×1 topic
  31. Refolding24▲ 212×1 topic
  32. Children23▲ 14×3 topics
  33. Regulatory T Cells23▲ 27×4 topics
  34. Guidelines22▲ 6.2×9 topics
  35. Tumor Regression20▲ 24×2 topics
  36. Gene Therapy20▲ 14×6 topics
  37. Inflammatory Diseases20▲ 14×4 topics
  38. Leukemia20▲ 31×2 topics
  39. CAR T Cells19▲ 35×1 topic
  40. Chimeric Antigen Receptor19▲ 35×1 topic

Which research topics does Regeneron (United States) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, Asthma and respiratory diseases, Dermatology and Skin Diseases and Protein purification and stability.

Monoclonal and Polyclona…31Monoclonal and Polyclonal Antibodies Research: 31 fractional worksAsthma and respiratory d…28Asthma and respiratory diseases: 28 fractional worksDermatology and Skin Dis…24Dermatology and Skin Diseases: 24 fractional worksProtein purification and…24Protein purification and stability: 24 fractional worksCAR-T cell therapy research: 19 fractional worksEosinophilic Esophagitis: 16 fractional worksIL-33, ST2, and ILC Path…15IL-33, ST2, and ILC Pathways: 15 fractional worksCancer Immunotherapy and Biomarkers: 14 fractional worksViral Infectious Diseases and Gene Expression in Insects: 13 fractional worksVirus-based gene therapy research: 10 fractional works
Radiology, Nuclear Medicine and ImagingPhysiologyDermatologyMolecular Biology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 31 works
  2. 2 Asthma and respiratory diseases Physiology 28 works
  3. 3 Dermatology and Skin Diseases Dermatology 24 works
  4. 4 Protein purification and stability Molecular Biology 24 works
  5. 5 CAR-T cell therapy research Oncology 19 works
  6. 6 Eosinophilic Esophagitis Surgery 16 works
  7. 7 IL-33, ST2, and ILC Pathways Immunology 15 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 14 works
  9. 9 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 13 works
  10. 10 Virus-based gene therapy research Genetics 10 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available54.4%not open45.6%

World: 40% of research is openly available.

with international co-authors26.6%domestic only73.4%

World: 18% is written across borders.

How has Regeneron (United States)'s research output changed?

Output in 2022-2025 was 50% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Regeneron (United States) as a percentage of every work published that year, 0.0032% in 2024.

still counting0.0020%0.0040%Regeneron (United States)0.0028% in 20251990200020102020

Fractional works of Regeneron (United States) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting20%40%60%Regeneron (United States)15.7% in 2025all institutions10.0% in 2025200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 50.8% in 1993.

Other research institutions in Tarrytown

All research institutions in Tarrytown

Share Regeneron (United States)'s ranking

Regeneron (United States) on Science Explorer

A card with Regeneron (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website2Each links back here and updates with every snapshot

Its overall standing, then the domains, fields and subfields where Regeneron (United States) is in the world's top ten or its top 1%. Each has an image of its own.

Overall

Domains

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Regeneron (United States). Posts are plain text and can be reported.